Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Over 18 years of age and willing and able to provide informed consent.
Patients with no prior diagnosis of prostate cancer, who are planning to undergo prostate biopsy as clinical standard of care ("early detection cohort")
Including those men with:
Patients with a prior diagnosis of prostate cancer, who are currently managed with active surveillance, who are planning to undergo biopsy as clinical standard of care ("active surveillance cohort")
Exclusion criteria
Patients with any clinical contraindication to MRI
*Including but not limited to:
Patients with prior prostate surgery for prostate cancer (e.g. radical prostatectomy, focal ablation)
Primary purpose
Allocation
Interventional model
Masking
500 participants in 2 patient groups
Loading...
Central trial contact
Joseph Ippolito, M.D.; Alex Klim
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal